BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34135507)

  • 1. Structural basis of omega-3 fatty acid transport across the blood-brain barrier.
    Cater RJ; Chua GL; Erramilli SK; Keener JE; Choy BC; Tokarz P; Chin CF; Quek DQY; Kloss B; Pepe JG; Parisi G; Wong BH; Clarke OB; Marty MT; Kossiakoff AA; Khelashvili G; Silver DL; Mancia F
    Nature; 2021 Jul; 595(7866):315-319. PubMed ID: 34135507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A.
    Wood CAP; Zhang J; Aydin D; Xu Y; Andreone BJ; Langen UH; Dror RO; Gu C; Feng L
    Nature; 2021 Aug; 596(7872):444-448. PubMed ID: 34349262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate binding-induced conformational transitions in the omega-3 fatty acid transporter MFSD2A.
    Bergman S; Cater RJ; Plante A; Mancia F; Khelashvili G
    Nat Commun; 2023 Jun; 14(1):3391. PubMed ID: 37296098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mfsd2a utilizes a flippase mechanism to mediate omega-3 fatty acid lysolipid transport.
    Chua GL; Tan BC; Loke RYJ; He M; Chin CF; Wong BH; Kuk ACY; Ding M; Wenk MR; Guan L; Torta F; Silver DL
    Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2215290120. PubMed ID: 36848557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid flipping in the omega-3 fatty-acid transporter.
    Nguyen C; Lei HT; Lai LTF; Gallenito MJ; Mu X; Matthies D; Gonen T
    Nat Commun; 2023 May; 14(1):2571. PubMed ID: 37156797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye.
    Wong BH; Silver DL
    Adv Exp Med Biol; 2020; 1276():223-234. PubMed ID: 32705603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the lysophospholipid brain uptake mechanism and its inhibition by syncytin-2.
    Martinez-Molledo M; Nji E; Reyes N
    Nat Struct Mol Biol; 2022 Jun; 29(6):604-612. PubMed ID: 35710838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A.
    Quek DQ; Nguyen LN; Fan H; Silver DL
    J Biol Chem; 2016 Apr; 291(18):9383-94. PubMed ID: 26945070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.
    Nguyen LN; Ma D; Shui G; Wong P; Cazenave-Gassiot A; Zhang X; Wenk MR; Goh EL; Silver DL
    Nature; 2014 May; 509(7501):503-6. PubMed ID: 24828044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Placental Major Facilitator Superfamily Domain Containing 2a in Pregnant Mice Reduces Fetal Brain Growth and Phospholipid Docosahexaenoic Acid Content.
    Powell TL; Barentsen K; Vaughan O; Uhlson C; Zemski Berry K; Erickson K; Faer K; Chassen SS; Jansson T
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome.
    Guemez-Gamboa A; Nguyen LN; Yang H; Zaki MS; Kara M; Ben-Omran T; Akizu N; Rosti RO; Rosti B; Scott E; Schroth J; Copeland B; Vaux KK; Cazenave-Gassiot A; Quek DQ; Wong BH; Tan BC; Wenk MR; Gunel M; Gabriel S; Chi NC; Silver DL; Gleeson JG
    Nat Genet; 2015 Jul; 47(7):809-13. PubMed ID: 26005868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?
    Eser Ocak P; Ocak U; Sherchan P; Zhang JH; Tang J
    J Neurosci Res; 2020 Jan; 98(1):29-41. PubMed ID: 30345547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging decreases docosahexaenoic acid transport across the blood-brain barrier in C57BL/6J mice.
    Iwao T; Takata F; Matsumoto J; Aridome H; Yasunaga M; Yokoya M; Kataoka Y; Dohgu S
    PLoS One; 2023; 18(2):e0281946. PubMed ID: 36795730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination.
    Sengottuvel V; Hota M; Oh J; Galam DL; Wong BH; Wenk MR; Ghosh S; Torta F; Silver DL
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37104036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development.
    Wong BH; Chan JP; Cazenave-Gassiot A; Poh RW; Foo JC; Galam DL; Ghosh S; Nguyen LN; Barathi VA; Yeo SW; Luu CD; Wenk MR; Silver DL
    J Biol Chem; 2016 May; 291(20):10501-14. PubMed ID: 27008858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain.
    Chan JP; Wong BH; Chin CF; Galam DLA; Foo JC; Wong LC; Ghosh S; Wenk MR; Cazenave-Gassiot A; Silver DL
    PLoS Biol; 2018 Aug; 16(8):e2006443. PubMed ID: 30074985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into the mechanism of the sodium/iodide symporter.
    Ravera S; Nicola JP; Salazar-De Simone G; Sigworth FJ; Karakas E; Amzel LM; Bianchet MA; Carrasco N
    Nature; 2022 Dec; 612(7941):795-801. PubMed ID: 36517601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zika virus degrades the ω-3 fatty acid transporter Mfsd2a in brain microvascular endothelial cells and impairs lipid homeostasis.
    Zhou J; Chi X; Cheng M; Huang X; Liu X; Fan J; Xu H; Lin T; Shi L; Qin C; Yang W
    Sci Adv; 2019 Oct; 5(10):eaax7142. PubMed ID: 31681849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Major Facilitator Superfamily Domain-Containing 2a in the Central Nervous System.
    He Z; Zhao Y; Sun J
    Cell Mol Neurobiol; 2023 Mar; 43(2):639-647. PubMed ID: 35438385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination.
    Harel T; Quek DQY; Wong BH; Cazenave-Gassiot A; Wenk MR; Fan H; Berger I; Shmueli D; Shaag A; Silver DL; Elpeleg O; Edvardson S
    Neurogenetics; 2018 Dec; 19(4):227-235. PubMed ID: 30043326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.